Di Nuzzo Private Wealth, Inc. Guardant Health, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $697 Million
- Q3 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 11 shares of GH stock, worth $1,063. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 6
83.33%
Holding current value
$1,063
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
429Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA11.9MShares$1.15 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.09 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$496 Million0.25% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$481 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$411 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.89B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...